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Abstract
Atherosclerosis-associated diseases are the main cause of mortality and morbidity in western
societies. The progression of atherosclerosis is a dynamic process evolving from early to
advanced lesions that may become rupture-prone vulnerable plaques. Acute coronary syn-
dromes are the clinical manifestation of life-threatening thrombotic events associated with
high-risk vulnerable plaques. Hyperlipidemic mouse models have been extensively used in
studying the mechanisms controlling initiation and progression of atherosclerosis. However,
the understanding of mechanisms leading to atherosclerotic plaque destabilization has been
hampered by the lack of proper animal models mimicking this process. Although various
mouse models generate atherosclerotic plaques with histological features of human
advanced lesions, a consensus model to study atherosclerotic plaque destabilization is still
lacking. Hence, we studied the degree and features of plaque vulnerability in different mouse
models of atherosclerotic plaque destabilization and find that the model based on the place-
ment of a shear stress modifier in combination with hypercholesterolemia represent with high
incidence the most human like lesions compared to the other models.
Introduction
Acute coronary syndromes (ACS) are the main cause of morbidity and mortality in western
societies. Thrombotic events associated to plaque rupture are responsible of the majority of
ACS events [1, 2]. Rupture-prone plaques are archetypically characterized by exacerbated infil-
tration of inflammatory leukocytes in combination with a large necrotic core (NC) covered by
a thin fibrous cap (FC) [3]. During plaque destabilization, enhanced macrophage and vascular
smooth muscle cell (VSMC) apoptosis fuel the NC enlargement. In addition, extracellular
matrix degradation and VSMC apoptosis induction by lesional proteases results in the loss of
the FC stability [4]. Structural damage in the FC results in the exposure of the highly thrombo-
genic material of the NC to the blood, leading to thrombus formation, occlusion of the coro-
nary artery, and associated ACS [5]. Albeit the clinical relevance of this process, the
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understanding of the mechanisms underlying the conversion of a stable into an unstable and
ruptured plaque remains unclear.
Various mouse models have been proposed in the last decades to study the process of ath-
erosclerotic plaque destabilization. Generation of vulnerable plaques has been achieved by
diverse strategies including genetic modifications, surgical techniques or combination of both
in genetically-modified hypercholesterolemic mouse models (reviewed in [4]). Murine vulner-
able plaques resemble some features of advanced human plaques such as large NC, thin FC
and the presence of intraplaque hemorrhages or neoangiogenesis. On the other hand, plaque
rupture and associated thrombotic events are almost never detected. Besides these differences
between murine and human vulnerable lesions, mouse models may be highly helpful in the
study of the pathomechanisms that lead to vulnerable plaques prior to rupture [5, 6]. However,
a consensus model of mouse atherosclerotic plaque destabilization is still lacking.
In this study, we aimed to evaluate the degree of plaque vulnerability in different mouse
model of atherosclerotic plaque destabilization. [7–9]. We employed two models in apolipo-
protein E deficient (Apoe-/-) mice of local shear stress alteration based on the partial ligation of
and/or the implantation of a shear stress modifier device in the left common carotid artery
were employed. In addition, we induced endogenous renovascular hypertension through par-
tial ligation of the left renal artery. Finally, we examined the effect of aggravated hypercholes-
terolemia on plaque development in these models by feeding the mice chow or high fat diet. In
conclusion, we observed that the model based on the implantation of a shear stress modifier
device under hypercholesterolemia exhibited higher incidence of human-like vulnerable ath-
erosclerotic plaques formation and reduced variability between specimens.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was
approved by the Committee on the Ethics of Animal Experiments of the University of Amster-
dam and the Animal Research Institute (ARIA), Amsterdam (Permit Number: DBC102939
and DBC102940). All animal experiments were conducted in the animal facility of the Aca-
demic Medical Center (AMC, Amsterdam). All surgeries were performed under isoflurane
anesthesia, and all efforts were made to minimize suffering.
Mice
Sex-matched groups weighing 20–25g were enrolled in this study. Male apolipoprotein E defi-
cient mice (Apoe-/-) (8 weeks-old) were subjected to combined partial ligation of the left com-
mon carotid artery (LCCA) and the left renal artery (LRA, n = 10, Fig 1A) or cast placement
around the LCCA and partial ligation of the LRA (n = 10, Fig 1B). Females (8 weeks-old) were
either subjected to partial ligation of the LCCA and cast placement (n = 10, Fig 1C) or only cast
implantation (n = 10, Fig 1D). Mice were fed ad libitum with chow diet (CD) or high fat diet
(HFD, 22% fat and 0.15% cholesterol, abdiets, Weerden, The Netherlands) when indicated and
during the periods described in Fig 1.
Surgery procedure
A detailed listing of the methodological modifications from the originally reported intervention
is provided in the online supplemental materials (Tables A-D in S1 File). All mice undergoing
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surgery were injected s.c. with Temgesic 30min before surgery and in the evening after to allevi-
ate the suffering during the surgical procedure and to ensure the post-surgical recovery.
Partial ligation of the left common carotid artery. The partial ligation of the LCCA was
performed as described by [10]. In brief, mice were anesthetized with isoflurane via inhalation
through a nose mask and were maintained throughout the surgery at 37°C on a heating pad.
Next, the anterior cervical triangles were accessed by a sagittal anterior neck incision. The
LCCA was individualized from circumferential connective tissues by blunt dissection and the
exposed branches of the LCCA but not the superior thyroid artery (LSTA) was permanently
ligated with a surgical suture (7–0 silk) (Fig 1A and 1C). After validating that blood flow was
present through the LCCA the incision was closed with suture (6–0 silk).
Fig 1. Schematic diagrams and experimental setups of the mousemodels of atherosclerotic plaque destabilization. (A) Model based on the
combined partial ligation of LCCA (left) and LRA (right). (B) Model based on the combination of cast placement around LCCA (left) and partial ligation of LRA
(right). (C) Model based on the partial ligation of LCCA in combination with the cast placement around the LCCA. (D) Model based on cast placement around
the LCCA. LCCA: left common carotid artery; LRA: left renal artery; LECA: left external carotid artery; LICA: left internal carotid artery; LSTA: left superior
thyroid artery; CD: chow diet; HFD: high fat diet; Lig.: ligation.
doi:10.1371/journal.pone.0141019.g001
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Partial ligation of the left renal artery. Mice were subjected to endogenous renovascular
hypertension using modified LRA ligation as described by Jin et al. [8]. In brief, mice were
anesthetized with isoflurane via inhalation through a nose mask and were maintained through-
out the surgery at 37°C on a heating pad. After a small flank incision the left kidney was
exposed and the LRA was ligated with a surgical suture (6–0 silk) along with a spacer (outer
diameter 0.11mm) (Fig 1A and 1B). Subsequently, the spacer was removed leaving a tight ste-
nosis in the LRA. Thereafter, the kidney was gently placed back into the retroperitoneal cavity
and the muscle layer and the skin were closed with suture (6–0 silk). To test the successful
induction of endogenous renovascular hypertension, significant shrinkage of the left kidney
was observed (Figure A in S1 File). In addition, systolic blood pressure was measured using a
sphygmomanometer and the tail-cuff method before the surgery and every 2 weeks after the
surgery (Figure A in S1B–S1E File).
Cast placement around the left common carotid artery. To induce local changes in shear
stress in the LCCA we used the cast as described by Cheng and colleagues [9]. This device con-
sists of two longitudinal halves of a cylinder with a cone-shaped lumen (constructive diameter
0.2mm) (Fig 1B–1D). Mice were anesthetized with isoflurane via inhalation through a nose
mask and were maintained throughout the surgery at 37°C on a heating pad. The anterior cer-
vical triangles were accessed by a sagittal anterior neck incision. The LCCA was individualized
from circumferential connective tissues by blunt dissection and the cast was placed around the
LCCA. After validating that blood flow was present through the LCCA the incision was closed
with suture (6–0 silk).
Tissue processing
Mice were euthanized by CO2 inhalation in a euthanasia chamber. After collecting blood via
heart puncture, animals were perfused with 20ml PBS, pH 7.4. Next, the LCCA was removed
and embedded in OCT compound (Tissue-Tek, Sakura Finetek, Torrance, CA). Samples were
frozen on isopentane and liquid nitrogen and stored at -20°C. Haematologic counts were deter-
mined with the ScilVet abc Plus analyzer (scil animal care company GmbH, Viernheim, Ger-
many) (Figure B in S1 File).
Histological and Immunofluorescence staining
Cryosections (7μm) were histologically stained with standard hematoxylin and eosin (H&E) in
intervals of 70μm. Consecutive sections were stained with picrosirius red for collagen and
Pearls’ Prussian blue staining for identification of intraplaque hemorrhages (IPH). Collagen
fiber composition was evaluated using polarized light illumination. MMP9 immunohistochem-
istry was performed using a ´mouse-on-mouse´ strategy as described in Goodpaster et al [11].
In brief, cryosections were air-dried and fixed with cold acetone. Mouse anti-human MMP9
(R&D, Minneapolis, USA) was pre-incubated with a rabbit Fab anti-mouse IgG (Rockland,
Limerick, USA) antibody and added to the cryosections in a dilution (1:100). After extensive
washing, sections were incubated with BrightVision poly-horseradish peroxidase-anti-rabbit
IgG (Immunologic BV, Duiven, The Netherlads) and visualized by DAB (3,3' diaminobenzi-
dine, ImmunoLogic, Duiven, The Netherlands). Counterstaining for the nuclei was performed
by incubation with hematoxylin. For immunofluorescence staining, cryosections were air-
dried and fixed with cold acetone. Next, specimens were blocked with 5% horse serum/PBS
and incubated with primary antibodies rabbit anti-mouse CD68 (1:200, Abcam, Cambridge,
MA), rat anti-mouse CD86 (1:500, BioLegend, San Diego, USA), alexa Fluor 647-conjugated
rat anti-mouse CD301 (1:500, AbD Serotec, Kidlington, UK) and FITC-conjugated mouse
anti-mouse smooth muscle cell α-actin (SMA, 1:1000, Sigma-Aldrich, St. Louis, MO). After
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extensive washing, sections were incubated with Alexa Fluor 488 or 647 donkey anti-rabbit
and Alexa Fluor 594 donkey anti-rat (1:500, Invitrogen, Breda, The Netherlands). Counter-
staining for the nuclei was performed by incubating with DAPI (Invitrogen). Images were
acquired with a laser microscope (TCS/SP8, Leica, Wetzlar, Germany).
Atherosclerotic plaque analysis
Atherosclerotic plaque analysis was performed on sections recollected after the suture in the
LCCA LRA and LCCA Cast models and in the low shear stress region generated by cast place-
ment in LRA Cast and Cast models. Carotid samples showing thrombus or absence of lesion
formation were excluded from this analysis. Histological sections were quantified by com-
puter-assisted morphometric analysis using ImageJ software (National Institutes of Health,
Bethesda, MD). Intima to media ratio was calculated as the quotient of intima and media areas
(μm2). Necrotic cores (NC) were defined as area absent of nuclei underneath a formed fibrous
cap (FC). Since tissue loss was observed in H&E compared to picrosirius red stained sections,
the NC core was assessed using these different staining (Figure C in S1 File). FC thickness was
defined as the average of lengths measurements in the positions overlapping with the lines of a
square-shaped grid.
Lesion classification
Lesions were scored blinded by two independent, very experienced pathologists with little
inter- and intra-variability. The classification was based on the following scoring: early, accu-
mulation of VSMCs, absence of lipid or macrophage foam cells; advanced type I, multiple lay-
ers of macrophage foam cells; advanced type II, multiple layers of macrophage foam cells, well-
formed NC covered by a thin FC, rare VSMCs and collagen content, eventually IPH; advanced
type III, neointimal thickening, highly increased intimal thickening, high amount of VSMCs
and macrophages, partial NC formation; complicated, presence of luminal thrombus (Table E
in S1 File).
Vulnerability-Index (VI and VIc)
Vulnerability-Index (VI) was used to evaluate the overall degree of vulnerability between the
models by integrating all plaque features analyzed in the study. VI was adapted from [12]. VI
was calculated by the relation between analyzed unstable (U) and stable (S) features of the pla-
que and corrected by the incidence of lesion formation (p, VIc). The formula for VI was
expressed as VIc(i) = (U(i)/S(i)), where i represents each studied mouse. The formula for cor-
rected VI was expressed as VIc(i) = (U(i)/S(i))p(i), where i represents each studied mouse. U
includes the sum of NC area (% of intima), CD68+ area (% of intima) and of Pearls’ Prussian
blue+ area (% of intima). S consists of SMA+ area (% of intima) and collagen+ area (% of
intima). Analysis of VI and VIc were performed on lesions with the same severity score of type
II (see above). Lesions not representing the type II phenotype were scored as zero.
Statistical analysis
All data were represented as individual data points along with mean values. For the individual
parameters was no statistical analysis performed due to the evaluation of the features of the
regarded model itself. Statistical analysis was performed for the VIc as comparison of the mod-
els among themselves. Statistical analysis was done with GraphPad Prism 5 (GraphPad Soft-
ware, LaJolla, CA). Unpaired Student’s t-test or Mann-Whitney (one variable) or one-way
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ANOVA with Bonferroni’s Multiple Comparison test (> 2 variables) were applied, as appro-
priate. p-values< 0.05 were considered as being statistically significant.
Results
Mouse model description and incidence of lesion formation
We performed 4 different mouse models of atherosclerotic plaque destabilization adapted from
previous described studies [7–9]. First, Apoe-/- mice were subjected to alteration of blood flow
in the LCCA by partial ligation (Fig 1A) or implantation of a shear stress modifier (cast, Fig
1B) as described in [9]. Hypertension has been shown to increase signs of plaque vulnerability,
thus we performed partial ligation of the LRA in combination with mentioned blood flow alter-
ations [8]. We observed successful induction of hypertension as determined by a significant
increase in the systolic blood pressure 2 weeks after the surgery and the shrinkage of the left
kidney (Figure A in S1 File). In addition, we performed another model based on alteration of
the blood flow by partial ligation and subsequent implantation of a cast in the LCCA of Apoe-/-
mice (Fig 1C). This method generates a diminished blood flow in the carotid bifurcation and
the low shear-stress region of the cast accelerating the formation of the atherosclerotic lesion,
as described in [7]. Of note, we substituted the cuff for the cast implantation in order to gener-
ate the lesion in a more predictable location as observed with the fixed constructive diameter
(0.2mm) of the cast [7]. All these models were performed under CD or HFD. Finally, we stud-
ied a model solely based on cast implantation in the LCCA of Apoe-/- mice under HFD regime
as described by Cheng et al. (Fig 1D). As shown in Fig 2, we observed a difference in the inci-
dence of atherosclerotic plaque formation (including VSMC rich neointimas) between the dif-
ferent models: LCCA LRA (CD: 80%, HFD: 89%), LRA Cast (CD: 40%, HFD: 30%), LCCA
Cast (CD: 40%, HFD: 80%) and Cast HFD: 70%. Absence of atherosclerotic plaque was defined
as the presence of a non-lesion associated luminal thrombus or the absence of lesions (non-
responders) in the left carotid artery.
Analysis of structural features of the atherosclerotic plaques
Additionally to the incidence of lesion formation, we examined the structural phenotype of
formed lesions. Of note, carotid samples showing thrombus or absence of lesion formation
were excluded from this analysis. Based on this criteria, the number of excluded carotid sam-
ples in the LRA Cast model (CD and HFD) comprised the majority of studied samples, there-
fore the following analysis were not performed in these models. First, we analyzed lesion size
defined as intima to media ratio. Assessed mouse models exhibited differential intima to media
ratios: LCCA LRA (CD: 5.5 ± 2.2, HFD: 3.8 ± 2.4), LCCA Cast (CD: 2.8 ± 2.2, HFD: 3.8 ± 1.8)
and Cast HFD: 3.7 ± 1.2 (Fig 3B). Besides an expanded plaque size, enlarged NC and thin FC
better define human vulnerable plaques [3]. Thus, we explored the NC formation in sections of
studied specimens. Overall, we found different incidence of NC formation (0–70%) and varia-
tions in size (%NC of intimal area): LCCA LRA (CD: 10.9 ± 2.8%, HFD: 20.4 ± 10.0%), LCCA
Cast (CD: 17.7%, HFD: 21.0 ± 10.6%) and Cast HFD: 13.2 ± 5.0% (Fig 3C). In the sections
where a NC was present, FC thickness was measured showing: LCCA LRA (CD:
59.7 ± 31.6μm, HFD: 19.1 ± 4.7μm), LCCA Cast (CD: 18.3μm, HFD: 33.1 ± 15.1μm) and Cast
HFD: 20.2 ± 7.4μm (Fig 3D).
Analysis of compositional features of the atherosclerotic plaques
Increased macrophage infiltration followed by decrease in VSMC and collagen content are
important indicators of plaque vulnerability [4]. Macrophage content detected by CD68
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immunostaining revealed variable infiltration into the intima: LCCA LRA (CD: 6.7 ± 4.0%,
HFD: 10.2 ± 4.8%), LCCA Cast (CD: 5.9 ± 6.0%, HFD: 9.7 ± 8.0%) and Cast HFD: 9.3 ± 6.0%
(Fig 4A). Additionally, the phenotype of the macrophages was characterized by analyzing
CD86 (marker of M1 or classical phenotype) and CD301 (marker of M2 or alternative pheno-
type) for the models LCCA LRA CD and Cast HFD (Figure D in S1 File). Analysis of the CD68
and CD86 positive macrophage content showed an increase in Cast HFD compared to LCCA
LRA CD (5.47 ± 2.55% vs 10.98 ± 2.39%). On the other hand, a decrease in CD68 and CD301
positive macrophages was detected in the model Cast HFD compared to LCCA LRA CD
(0.55 ± 0.23% vs 0.11 ± 0.04%) (Figure D in S1 File). Furthermore, we analyzed lesional VSMC
content, an indicator of plaque stability. Quantification of intimal SMA area resulted as follows:
LCCA LRA (CD: 20.5 ± 12.0%, HFD: 8.0 ± 4.6%), LCCA Cast (CD: 5.3 ± 3.8%, HFD:
9.4 ± 4.0%) and Cast HFD: 4.6 ± 3.6% (Fig 4B). Next, we measured intimal collagen by picrosir-
ius red staining. The percentage of collagen positive area within the intima was: LCCA LRA
(CD: 44.1 ± 23.4%, HFD: 35.6 ± 16.0%), LCCA Cast (CD: 15.9 ± 18.4%, HFD: 29.9 ± 12.6%)
Fig 2. Representative carotid cross-sections of studied specimens for the mousemodels of
atherosclerotic plaque destabilization.Mice were fed chow diet (CD) or high fat diet (HFD) as indicated.
From left to right: LCCA LRA, model based on the combination of partial ligation of LCCA and LRA; LRA
Cast, model based on the combined cast placement around LCCA and partial ligation of LRA; LCCA Cast,
model based on the partial ligation of LCCA in combination with the cast placement around the LCCA; Cast,
model based on cast placement around the LCCA. Red, yellow and green bars represent thrombus, no lesion
or atherosclerotic lesion, respectively. Scale bar = 100μm. LCCA: left common carotid artery; LRA: left renal
artery; CD: chow diet; HFD: high fat diet.
doi:10.1371/journal.pone.0141019.g002
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and Cast HFD: 36.2 ± 13.2% (Fig 4C). Detailed analysis of the collagen content demonstrates a
significant difference between thin and thick fibers for the model Cast HFD (thick fibers:
71.92 ± 7.47%, thin fibers: 24.60 ± 6.75%), whereas no significant difference was shown for the
model LCCA LRA CD (thick fibers: 42.64 ± 8.23%, thin fibers: 54.39 ± 8.32%) (Figure E in S1
File). Additionally, it has been demonstrated that matrix metalloproteinases (MMPs) degrade a
broad range of matrix substrates like elastin, collagen and fibronectin [13]. Thus we analyzed
the content of MMP9 within the lesions of the models LCCA LRA CD and Cast HFD (Figure F
in S1 File). A significant content increase of MMP9 was detected in the model Cast HFD
Fig 3. Structural features of the atherosclerotic lesions.Quantification of (A) intimal area, (B) intima to media ratio, (C) necrotic core size and (D) fibrous
cap thickness. Fibrous cap thickness was only measured when necrotic core was present. NC: necrotic core; FC: fibrous cap; CD: chow diet; HFD: high fat
diet; LCCA: left common coronary artery; LRA: left renal artery.
doi:10.1371/journal.pone.0141019.g003
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compared to LCCA LRA CD (10.98 ± 3.26% vs 31.75 ± 8.45%) (Figure F in S1 File). Neoangio-
genesis and IPH are independent factors associated with plaque instability and thrombotic
events [14]. Detection of IPH has been previously described in different mouse models of ath-
erosclerotic plaque destabilization [8, 9, 15]. Hence, we aimed to assess the presence of IPH in
our mouse models. IPHs were frequently occurring in the models LCCA Cast (CD: 50%, HFD
Fig 4. Compositional features of the atherosclerotic lesions.Quantification of (A) macrophage (CD68+ area), (B) vascular smooth muscle cell (SMA
+ area) and (C) total collagen (picrosirius red+ area) content. (D) Quantification of the incidence of intraplaque hemorrhage in Pearls’ Prussian blue stained
sections. CD: chow diet; HFD: high fat diet; LCCA: left common coronary artery; LRA: left renal artery; IPH: intraplaque hemorrhages.
doi:10.1371/journal.pone.0141019.g004
Mouse Models of Vulnerable Plaque
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62.5%) and LCCA LRA (CD: 50%) (Fig 4D), whereas in the model Cast HFD IPH was unde-
tectable. On the other hand, analysis of neovessels by CD31 staining was negative in all samples
analyzed (data not shown). This discrepancy has been also described by others [16].
Plaque classification and determination of the Vulnerability-Index
To integrate all parameters analyzed, we first classified the atherosclerotic lesions as described
in Material and Methods as our type II lesions that represents vulnerable plaques with thin
fibrous cap atheroma (TCFA) phenotype (Table E in S1 File). Except for LRA Cast under chow
diet, all models exhibited type II advanced plaques (Figure G in S1 File). We next calculated the
vulnerability-index that allowed us to integrate all parameters analyzed and determine the
degree of vulnerability between the models. The index includes the components of increasing
and decreasing factors of plaque instability (Table 1). After correction with the incidence of the
type II lesion formation (see Material and Methods), we calculated the following indices:
LCCA LRA (CD: 0.004 ± 0.01, HFD: 0.07 ± 0.1), LCCA Cast (CD: 0.02 ± 0.03, HFD:
0.12 ± 0.18) and Cast HFD: 0.45 ± 0.36 (Table 1).
Discussion
Rupture of human culprit atherosclerotic plaques is preceded by the conversion of a stable into
an unstable atherosclerotic plaque. Post-mortem analyses of human specimens have defined
the characteristics of the archetypical vulnerable plaques responsible for most of the throm-
botic events associated with ACS. However, the study of the mechanisms underlying the pro-
cess of atherosclerotic plaque destabilization has been hampered by the lack of proper animal
models. Reported mouse models of atherosclerotic plaque destabilization describe the forma-
tion of advanced atheromas exhibiting different signs of plaque instability such as NC expan-
sion, FC thinning and an inflammatory phenotype [4]. Additional destabilizing features such
as neoangiogenesis or IPH [7, 9, 15] are eventually detected while others such as plaque disrup-
tion with superimposed thrombosis can hardly be identified [15, 17, 18]. Indeed, it is well
accepted that mouse atherosclerotic plaques only partly resemble the characteristics observed
in human advanced lesions. However, the advantages of identifying novel mechanistic path-
ways in experimental atherosclerosis models highlight the importance of establishing a consen-
sus model of plaque destabilization in mice.
The goal of the present study was to compare different mouse models of atherosclerotic pla-
que destabilization to analyze the degree of lesion instability and the robustness of the model.
Elevated blood pressure is a major risk of cardiovascular diseases and blood-pressure lowering
Table 1. Vulnerability-Index of the lesions in the mousemodels of atherosclerotic plaque destabilization.
Vulnerability-Index (VI) Incidence of type II Corrected Vulnerability-Index (VIc) p-value (vs Cast HFD)
LCCA LRA CD 0.32 1/10 0.004 ± 0.01 < 0.001
LCCA LRA HFD 0.55±0.32 3/9 0.07 ± 0.1 < 0.01
LCCA Cast CD 0.61 1/10 0.02 ± 0.03 < 0.01
LCCA Cast HFD 1.05±0.54 3/10 0.12±0.18 < 0.05
Cast HFD 0.65±0.51 7/10 0.45±0.36 -
Vulnerability-Index (VI) was calculated by the relation between analyzed unstable (U) and stable (S) features of the plaque and corrected by the incidence
of lesion formation (p, VIc). Lesions not representing the type II phenotype were scored as zero. SD was not indicated for models with incidence of n = 1 of
type II lesions. LCCA: left common coronary artery; LRA: left renal artery; CD: chow diet; HFD: high fat diet. (n = 3–8; p < 0.05, p < 0.01, p < 0.001 with
1-way ANOVA with Bonferroni’s Multiple Comparison test)
doi:10.1371/journal.pone.0141019.t001
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therapies significantly reduce events of ACS [19]. Induction of hypertension by angiotensin II
infusion or constriction of the renal artery has been shown to increase signs of vulnerability in
mouse models of advanced atherosclerosis [8, 9]. Hence, we performed a mouse model based
on renovascular hypertension by partial ligation of the LRA combined with induction of low
shear stress in the carotid artery through partial ligation of or implantation of a shear stress
modifier (cast) in the LCCA. Under chow diet regime, partial ligation of the LRA and LCCA
generated neointimal thickening-type atherosclerotic lesions with expanded size and VSMC-
enriched phenotype compared to HFD feeding condition. In line with these results, angiotensin
II infusion has been shown to increase VSMC response by increasing proliferation and migra-
tion leading to neointimal thickening [20]. The formation of a NC, thinning of the FC,
increased macrophage infiltration and the reduction of collagen and VSMC content, which are
critical factors of human plaque destabilization [3], were detected in a lower extent. Overall,
based on our criteria the features that define human-like plaque vulnerability are not fulfilled
by the LCCA LRA model under CD. On the other hand, these factors were induced by HFD
feeding, probably through increasing macrophage infiltration, leading to a more vulnerable
phenotype. Under hypertensive conditions, alteration of the blood flow by implantation of a
cast in the LCCA exhibited a reduced incidence of lesion formation compared to partial liga-
tion of the LCCA both under CD or HFD regime. Intense reduction of the blood flow by partial
ligation of the LCCA compared to that generated by the constrictive diameter of the cast (0.2
mm) may explain the differences in the incidence of lesion formation. Moreover, out of all
identified lesions, a predominance of early neointimal thickening lesions or type I advanced
lesions was observed, suggesting lower progression of the atherosclerotic disease. A limitation
of the study is that although observing a significant increase of the blood pressure 2–4 weeks
after LRA partial ligation, the blood pressure in models LCCA LRA and LRA Cast under HFD
was subsequently stabilized. Hence, the time-point of analysis may be suboptimal since the
effect of hypertension on atherosclerotic plaque destabilization was no longer present.
In addition, we evaluated a mouse model of atherosclerotic plaque destabilization involving
the partial ligation of LCCA followed by the implantation of a constrictive cast four days before
sacrifice. Compared to the model previously reported by Sasaki and colleagues [7], we substi-
tuted the use of a polyethylene cuff for a cast to reduce the variability in the extent of artery
constriction. As reported by Sasaki et al [7] and as observed in the model involving partial liga-
tion of the LCCA and LRA, mice developed VSMC-enriched neointimal thickening lesions
under CD feeding. Furthermore, in agreement with Sasaki’s work, we evidenced a higher pres-
ence of occlusive or mural thrombus. As mentioned above, human plaque rupture requires the
contact of NC content with the vessel lumen through a disrupted FC which can be associated
with the formation of a superimposed thrombus. Based on this definition, we however could
not identify signs of plaque disruption as a cause of the observed thrombus formation. Of note,
the use of a constrictive cast instead of the polyethylene cuff may explain these observations.
Similarly, thrombus formation in the model involving partial ligation of the LCCA and LRA
was neither associated to plaque disruption. As previously observed feeding with HFD boosted
inflammatory macrophage infiltration, increased NC formation and reduced the number of
excluded specimens due to thrombus formation or absence of lesion formation.
Finally, we used the model described by Cheng and colleagues where Apoe-/- mice were sub-
jected to the implantation of a cast in the LCCA [9]. As predicted, advanced atherosclerotic
lesions where formed in the cast region with low shear stress in respect to the high shear or
oscillatory stress regions (data not shown). This model involved a longer period of HFD feed-
ing (11 weeks) which was associated with the formation of TFCA with expanded NC and thin-
ner FC and exhibiting an inflammatory phenotype.
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Adequate assessment of atherosclerotic plaque vulnerability enables us to integrate data
obtained from the study of different structural and compositional factors with functional impli-
cation in plaque instability. We have developed an index of plaque instability (VI) to quantita-
tively study lesion severity and vulnerability in a simple way. This index includes a ratio of
destabilizing factors such as NC size, macrophage content or IPH presence and factors with a
stabilizing function like VSMC and collagen content. This ratio was combined with the inci-
dence of the vulnerable type II lesions in the respectable model. Of note, other criteria could be
included in this index that can be relevant in different experimental setups. In order to reduce
statistical variability and obtain more reliable results, we first classified the lesions according to
their severity degree using elements of the Virmani histopathological classification. For
instance, the partial ligation of the LCCA in combination with renovascular hypertension
model was characterized by a notable variability in the severity degree between the different
studied specimens. Moreover, different lesion types were found within the carotid artery sur-
face (data not shown) thereby increasing the difficulty to define the individual degree of vulner-
ability and augmenting the variability for each parameter analyzed. Since, advanced atheroma
type II (TFCA) resemble a higher number of characteristics associated with human atheroscle-
rotic vulnerable plaques we focused our analysis on this lesion type. Models based on partial
ligation of the LCCA combined with cast implantation under HFD regime or solely cast place-
ment showed a higher index of plaque instability. However, although exhibiting an increased
index of plaque instability, type II advanced plaques were found in lower extent in the model
LCCA Cast on HFD compared to the cast model. After correction of the index [3] with the
incidence of vulnerable plaque formation, the Cast model reflected a higher overall vulnerabil-
ity in compared to LCCA Cast on HFD model.
Collectively, we have observed that the mouse model based on the cast implantation under
hypercholesterolemia exhibited increased incidence of human-like atherosclerotic vulnerable
plaques with less variability between the analyzed specimens (Table 2). It is worth mentioning,
that all models displayed different instability traits associated with human atherosclerotic pla-
que vulnerability. For instance, we were not able to detect IPH in the cast HFD model com-
pared to the other models, although Cheng et al. reported a spontaneous or angiotentin II-
induced incidence of 29% vs 75%. This variation may be due to different staining and analysis
techniques [9]. In addition, we believe that the different gender has no impact on the
Table 2. Summary of features of the plaque destabilization models.
LCCA LRA CD LCCA LRA HFD LRA Cast CD LRA Cast HFD LCCA Cast CD LCCA Cast HFD Cast HFD
Technical challenge ••• ••• •• •• •• •• •
Duration •• •• •• •• • • •••
Non-Responders •• • ••• ••• ••• •• ••
Robustness (VI, VIc) • •• - - • ••• •••
Human-like • • - - • •• •••
Incidence of
-mural Thrombus •• - - - ••• •• -
-Lesion ••• ••• - - • ••• •••
-TFC/NC •• •• - - • •• •••
-IPH ••• ••• - - ••• ••• -
• low •• medium ••• high—n/a
LCCA: left common coronary artery; LRA: left renal artery; CD: chow diet; HFD: high fat diet; VI: Vulnerability-Index; VIc: corrected Vulnerability-Index; FC:
fibrous cap; NC: necrotic core; IPH: intraplaque hemorrhage.
doi:10.1371/journal.pone.0141019.t002
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development of the lesions type II, based on the study of Jin et al. using sex-matched groups
[8]. Taken together these findings highlight the fact that the selection of a model will depend of
the research question that is going to be addressed (Table 2). For example, the duration of the
model may limit the application of drug/antibody treatments that can only be applied for a spe-
cific maximum period of time. Furthermore, mice undergoing two sequential surgeries as
LRA/LCCA followed by cast placement may display a higher distress which could have an
additional impact on the results (Table 2). Of note, the models analyzed in this study did not
exhibit signs of thrombotic events associated either with plaque disruption or erosion. This
aspect highlights the previously described limitations of mouse models in studying thrombotic
events and subsequent clinical outputs such as myocardial infarction or stroke [16]. Nonethe-
less, events occurring during human atherothrombosis (late stages of atherosclerotic disease)
preceding plaque rupture, such as NC formation, lesional cell-death or fibrotic tissue degrada-
tion are still detected in these mouse models. An additional possibility to study plaque vulnera-
bility would be the use of humanized mouse. These humanized mouse models have been
shown to possess different capabilities of engrafting human hematolymphoid cells [21, 22]. But
they bring also limitations, thus it would not include the impact of SMC or collagen content in
the progression of the plaque destabilization and could just give information about the impact
of hematolymphoid cells. Interestingly, the vast use of mouse models to study atherogenesis
has resulted in tremendous progress in the identification of novel molecular targets for treat-
ment of early atherosclerosis. However its clinical application has been restricted since patients
are not usually treated during early phases of the disease. On the other hand, mouse models of
atherosclerotic plaque destabilization may help to identify molecular mechanisms involved in
advanced atherosclerosis development that could be more easily translated to the clinical prac-
tice. Combination of this knowledge with novel imaging techniques and biomarker screening
may allow for earlier detection and subsequent treatment of patients with subclinical silent vul-
nerable lesions before resulting in fatal ACS.
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